Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kurt van Der Speeten

Showing results (1-10 of 50) with videos related to

Pageof 5
Sort By:
Journal of Gastrointestinal Oncology|March 5, 2016
Surgical technology and pharmacology of hyperthermic perioperative chemotherapyPaul H Sugarbaker, Kurt Van der Speeten
Case Reports in Oncology|March 8, 2013
Rhabdomyolysis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a case reportRob Bielen, Geert Verswijvel, Kurt Van der Speeten
World Journal of Gastroenterology|September 29, 2016
Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneumLieselotte Lemoine, Paul Sugarbaker, Kurt Van der Speeten
Case Reports in Oncology|November 10, 2010
An Unusual Case of Peritoneal CarcinomatosisStijn Hillewaere, Linde Stessens, Kurt Van der Speeten
Pleura and Peritoneum|March 27, 2019
Overview of the optimal perioperative intraperitoneal chemotherapy regimens used in current clinical practiceKurt Van der Speeten, Lieselotte Lemoine, Paul Sugarbaker
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|May 26, 2017
Drugs, doses, and durations of intraperitoneal chemotherapy: standardising HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesotheliomaLieselotte Lemoine, Paul Sugarbaker, Kurt Van der Speeten
Surgical Oncology|December 7, 2021
The many faces of intraperitoneal chemotherapyHisham Abdel Mageed, Kurt Van Der Speeten, Paul Sugarbaker
Frontiers in Oncology|April 5, 2021
Peritoneal Metastases From Colorectal Cancer: Defining and Addressing the ChallengesOnno Kranenburg, Kurt van der Speeten, Ignace de Hingh
Current Drug Discovery Technologies|March 12, 2009
Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancyKurt Van der Speeten, Oswald Anthony Stuart, Paul H Sugarbaker
Cancer Journal (Sudbury, Mass.)|June 27, 2009
Pharmacokinetics and pharmacodynamics of perioperative cancer chemotherapy in peritoneal surface malignancyKurt Van der Speeten, Oswald A Stuart, Paul H Sugarbaker
Pageof 5

Showing results (1-10 of 50) with videos related to

Sort By:
Pageof 5
Journal of Gastrointestinal Oncology|March 5, 2016
Surgical technology and pharmacology of hyperthermic perioperative chemotherapyPaul H Sugarbaker, Kurt Van der Speeten
Case Reports in Oncology|March 8, 2013
Rhabdomyolysis after cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a case reportRob Bielen, Geert Verswijvel, Kurt Van der Speeten
World Journal of Gastroenterology|September 29, 2016
Pathophysiology of colorectal peritoneal carcinomatosis: Role of the peritoneumLieselotte Lemoine, Paul Sugarbaker, Kurt Van der Speeten
Case Reports in Oncology|November 10, 2010
An Unusual Case of Peritoneal CarcinomatosisStijn Hillewaere, Linde Stessens, Kurt Van der Speeten
Pleura and Peritoneum|March 27, 2019
Overview of the optimal perioperative intraperitoneal chemotherapy regimens used in current clinical practiceKurt Van der Speeten, Lieselotte Lemoine, Paul Sugarbaker
International Journal of Hyperthermia : the Official Journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group|May 26, 2017
Drugs, doses, and durations of intraperitoneal chemotherapy: standardising HIPEC and EPIC for colorectal, appendiceal, gastric, ovarian peritoneal surface malignancies and peritoneal mesotheliomaLieselotte Lemoine, Paul Sugarbaker, Kurt Van der Speeten
Surgical Oncology|December 7, 2021
The many faces of intraperitoneal chemotherapyHisham Abdel Mageed, Kurt Van Der Speeten, Paul Sugarbaker
Frontiers in Oncology|April 5, 2021
Peritoneal Metastases From Colorectal Cancer: Defining and Addressing the ChallengesOnno Kranenburg, Kurt van der Speeten, Ignace de Hingh
Current Drug Discovery Technologies|March 12, 2009
Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancyKurt Van der Speeten, Oswald Anthony Stuart, Paul H Sugarbaker
Cancer Journal (Sudbury, Mass.)|June 27, 2009
Pharmacokinetics and pharmacodynamics of perioperative cancer chemotherapy in peritoneal surface malignancyKurt Van der Speeten, Oswald A Stuart, Paul H Sugarbaker
Pageof 5